Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Gutman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|August 4, 1995
FDA antibody rulesS I Gutman
Cytotherapy|April 30, 2010
FDA's new regulatory paradigms for in vitro diagnostic devicesM Robinowitz, S I Gutman
Clinical Chemistry|October 1, 1992
Simple, rapid method for determining nitrates and nitrites in biological fluidsS I Gutman, C A Hollywood
American Journal of Clinical Pathology|August 1, 1987
The clinical significance of dipstick-negative, culture-positive urines in a veterans populationS I Gutman, R R Solomon
Annals of Periodontology|March 1, 1997
Regulatory issues unique to clinical trials on periodontal diagnostic methods and devicesS I Gutman, C A Tylenda
American Journal of Clinical Pathology|April 1, 1980
Two new artifacts in automated coagulation testingS I Gutman, P Didisheim, H Markowitz
Antimicrobial Agents and Chemotherapy|April 1, 1989
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycinE A Gorzynski, S I Gutman, W Allen
Clinical Chemistry|October 1, 1988
Effect of nitroblue tetrazolium concentration on the fructosamine assay for quantifying glycated proteinH F Chung, H Lees, S I Gutman
American Journal of Diseases of Children (1960)|November 1, 1976
Malignant peritoneal mesothelioma in a childS I Gutman, P G Steinherz, G F Gray
American Clinical Laboratory|December 9, 1995
The FDA's perspective on clinical laboratory devices. The premarket review and evaluation processK J Aziz, C A Sliva, S I Gutman
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|August 4, 1995
FDA antibody rulesS I Gutman
Cytotherapy|April 30, 2010
FDA's new regulatory paradigms for in vitro diagnostic devicesM Robinowitz, S I Gutman
Clinical Chemistry|October 1, 1992
Simple, rapid method for determining nitrates and nitrites in biological fluidsS I Gutman, C A Hollywood
American Journal of Clinical Pathology|August 1, 1987
The clinical significance of dipstick-negative, culture-positive urines in a veterans populationS I Gutman, R R Solomon
Annals of Periodontology|March 1, 1997
Regulatory issues unique to clinical trials on periodontal diagnostic methods and devicesS I Gutman, C A Tylenda
American Journal of Clinical Pathology|April 1, 1980
Two new artifacts in automated coagulation testingS I Gutman, P Didisheim, H Markowitz
Antimicrobial Agents and Chemotherapy|April 1, 1989
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycinE A Gorzynski, S I Gutman, W Allen
Clinical Chemistry|October 1, 1988
Effect of nitroblue tetrazolium concentration on the fructosamine assay for quantifying glycated proteinH F Chung, H Lees, S I Gutman
American Journal of Diseases of Children (1960)|November 1, 1976
Malignant peritoneal mesothelioma in a childS I Gutman, P G Steinherz, G F Gray
American Clinical Laboratory|December 9, 1995
The FDA's perspective on clinical laboratory devices. The premarket review and evaluation processK J Aziz, C A Sliva, S I Gutman
Pageof 2